Lizhou Lin

1.2k total citations
24 papers, 1.0k citations indexed

About

Lizhou Lin is a scholar working on Biomedical Engineering, Biomaterials and Materials Chemistry. According to data from OpenAlex, Lizhou Lin has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Biomedical Engineering, 7 papers in Biomaterials and 6 papers in Materials Chemistry. Recurrent topics in Lizhou Lin's work include Ultrasound and Hyperthermia Applications (9 papers), Nanoplatforms for cancer theranostics (9 papers) and Nanoparticle-Based Drug Delivery (6 papers). Lizhou Lin is often cited by papers focused on Ultrasound and Hyperthermia Applications (9 papers), Nanoplatforms for cancer theranostics (9 papers) and Nanoparticle-Based Drug Delivery (6 papers). Lizhou Lin collaborates with scholars based in China, Netherlands and Portugal. Lizhou Lin's co-authors include Xiangyang Shi, Lianfang Du, Lianfang Du, Yu Fan, Peng Qin, Mingwu Shen, Qiusheng Shi, Yunchao Xiao, Lifang Jin and Fan Li and has published in prestigious journals such as Chemical Engineering Journal, Small and Dalton Transactions.

In The Last Decade

Lizhou Lin

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lizhou Lin China 18 656 308 293 254 202 24 1.0k
Lingxi Xing China 15 566 0.9× 345 1.1× 270 0.9× 274 1.1× 130 0.6× 19 945
Wei Tian China 16 685 1.0× 302 1.0× 286 1.0× 400 1.6× 167 0.8× 44 1.2k
Jingxing Si China 14 402 0.6× 292 0.9× 297 1.0× 150 0.6× 121 0.6× 31 856
Jueun Jeon South Korea 18 482 0.7× 316 1.0× 269 0.9× 174 0.7× 91 0.5× 27 913
Siyu Ma China 21 593 0.9× 267 0.9× 399 1.4× 246 1.0× 114 0.6× 69 1.4k
Fanghong Luo China 20 632 1.0× 377 1.2× 466 1.6× 247 1.0× 118 0.6× 57 1.2k
Tamer Refaat United States 12 484 0.7× 516 1.7× 395 1.3× 128 0.5× 142 0.7× 42 1.1k
Brian Wan-Chi Tse Australia 13 414 0.6× 214 0.7× 210 0.7× 172 0.7× 118 0.6× 24 822
Lia Appold Germany 10 894 1.4× 627 2.0× 390 1.3× 281 1.1× 132 0.7× 12 1.4k
Jurstine Daruwalla Australia 11 453 0.7× 671 2.2× 441 1.5× 150 0.6× 169 0.8× 17 1.3k

Countries citing papers authored by Lizhou Lin

Since Specialization
Citations

This map shows the geographic impact of Lizhou Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizhou Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizhou Lin more than expected).

Fields of papers citing papers by Lizhou Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lizhou Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizhou Lin. The network helps show where Lizhou Lin may publish in the future.

Co-authorship network of co-authors of Lizhou Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Lizhou Lin. A scholar is included among the top collaborators of Lizhou Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizhou Lin. Lizhou Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xijian, Chunlin Li, Jinxia Wang, et al.. (2022). Intracellular Mutual Amplification of Oxidative Stress and Inhibition Multidrug Resistance for Enhanced Sonodynamic/Chemodynamic/Chemo Therapy. Small. 18(13). e2107160–e2107160. 92 indexed citations
2.
Wang, Yeying, Yang Liu, Jinge Zhou, et al.. (2021). Controllable hydrogen release for gas-assisted chemotherapy and ultrasonic imaging of drug-resistant tumors. Chemical Engineering Journal. 421. 129917–129917. 29 indexed citations
3.
Jin, Lifang, Ruitao Wang, Lingling Zhuang, et al.. (2021). Evaluation of whole axillary status with lymphatic contrast-enhanced ultrasound in patients with breast cancer. European Radiology. 32(1). 630–638. 7 indexed citations
4.
Li, Gaoming, Yu Fan, Lizhou Lin, et al.. (2021). Two-dimensional LDH nanodisks modified with hyaluronidase enable enhanced tumor penetration and augmented chemotherapy. Science China Chemistry. 64(5). 817–826. 26 indexed citations
5.
Xu, F., Jianzhi Zhu, Lizhou Lin, et al.. (2020). Multifunctional PVCL nanogels with redox-responsiveness enable enhanced MR imaging and ultrasound-promoted tumor chemotherapy. Theranostics. 10(10). 4349–4358. 68 indexed citations
6.
Li, Dan, Lizhou Lin, Yu Fan, et al.. (2020). Ultrasound-enhanced fluorescence imaging and chemotherapy of multidrug-resistant tumors using multifunctional dendrimer/carbon dot nanohybrids. Bioactive Materials. 6(3). 729–739. 66 indexed citations
7.
Lin, Lizhou, et al.. (2020). The Long-Term Fate of the Sonoporated Pancreatic Cancer Cells is Uncorrelated With the Degree of Model Molecular Loading. Ultrasound in Medicine & Biology. 46(4). 1015–1025. 4 indexed citations
8.
Fan, Yu, Lizhou Lin, F Yin, et al.. (2020). Phosphorus dendrimer-based copper(II) complexes enable ultrasound-enhanced tumor theranostics. Nano Today. 33. 100899–100899. 35 indexed citations
10.
Zhu, Jianzhi, Zhicong Li, Changchang Zhang, et al.. (2019). Single enzyme loaded nanoparticles for combinational ultrasound-guided focused ultrasound ablation and hypoxia-relieved chemotherapy. Theranostics. 9(26). 8048–8060. 24 indexed citations
11.
Zhang, Yang, Zheying Meng, Yanjun Xu, et al.. (2019). Real-Time Elastography in the diagnosis of prostate cancer: a systematic review. Medical Ultrasonography. 21(3). 327–327. 4 indexed citations
12.
Lin, Lizhou, Yu Fan, Feng Gao, et al.. (2018). UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy. Theranostics. 8(7). 1923–1939. 130 indexed citations
13.
14.
Xiao, Yunchao, Mengyuan Wang, Lizhou Lin, et al.. (2018). Integration of aligned polymer nanofibers within a microfluidic chip for efficient capture and rapid release of circulating tumor cells. Materials Chemistry Frontiers. 2(5). 891–900. 26 indexed citations
15.
Xu, Gan, Zheng Wang, Jie Han, et al.. (2018). Design and synthesis of functionalized coordination polymers as recyclable heterogeneous photocatalysts. Dalton Transactions. 47(18). 6470–6478. 16 indexed citations
16.
Xu, Changsong, Bo Wang, Jufang Chen, et al.. (2017). TGF-β1 and TIMP1 double directional rAAV targeted by UTMD in atherosclerotic vulnerable plaque. Experimental and Therapeutic Medicine. 13(4). 1465–1469. 4 indexed citations
17.
Yang, Liu, Fan Li, Feng Gao, et al.. (2016). Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. Tumor Biology. 37(11). 15283–15291. 42 indexed citations
18.
Lin, Lizhou, Lifang Jin, Lianfang Du, et al.. (2016). Effect of acoustic parameters on the cavitation behavior of SonoVue microbubbles induced by pulsed ultrasound. Ultrasonics Sonochemistry. 35(Pt A). 176–184. 93 indexed citations
19.
Li, Fan, Feng Gao, Lingxi Xing, et al.. (2016). Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. Oncotarget. 7(26). 40148–40159. 44 indexed citations
20.
Liu, Yang, Fan Li, Feng Gao, et al.. (2016). Role of microenvironmental periostin in pancreatic cancer progression. Oncotarget. 8(52). 89552–89565. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026